Characterization of novel MPS1 inhibitors with preclinical anticancer activity

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

Guido Kroemer, Lorenzo Galluzzi, Peter Vandenabeele et al. · Cell Death and Differentiation · 2008 · 3.3K citations · Full text

Nomenclature Committee, Medicine, Apoptosis +8

Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs

Karen E. Gascoigne, Stephen S. Taylor · Cancer Cell · 2008 · 820 citations · Full text

Antimitotic Drugs, Oncology, Medicine +9

Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival

Maria Teresa Landi, Tatiana Dracheva, Melissa Rotunno et al. · PLoS ONE · 2008 · 686 citations · Full text

Aurora B-Mediated Abscission Checkpoint Protects against Tetraploidization

Patrick Steigemann, Claudia Wurzenberger, Michael H. A. Schmitz et al. · Cell · 2009 · 600 citations · Full text

Cell Regulation, Cell Division, Immune Checkpoint Inhibitor +4

Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine

Stefano Santaguida, Anthony Tighe, Anna Morena D’Alise et al. · The Journal of Cell Biology · 2010 · 544 citations · Full text